| RS191153391 |
HSD17B3
|
Health Risk |
Pathogenic/Likely pathogenic |
Testosterone 17-beta-dehydrogenase deficiency, Testosterone 17-beta-dehydrogenase deficiency |
| RS191154178 |
CDH23
|
Health Risk |
Conflicting classifications of pathogenicity |
CDH23-related disorder, CDH23-related disorder |
| RS191155035 |
ZSWIM6
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1911554964 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1911555382 |
GALNS
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-IV-A |
| RS1911556061 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1911557433 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1911558912 |
GALNS
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-IV-A |
| RS1911559787 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS191155989 |
NPR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Acromesomelic dysplasia 1, Maroteaux type |
| RS1911560774 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1911622593 |
PRPF8
|
Health Risk |
Pathogenic |
— |
| RS1911638529 |
PRPF8
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS191164314 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Cardiomyopathy |
| RS1911659345 |
PRPF8
|
Health Risk |
Pathogenic |
— |
| RS191166865 |
COL1A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS191171943 |
MYO15A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS191174682 |
VPS13B
|
Health Risk |
Conflicting classifications of pathogenicity |
Cohen syndrome, Inborn genetic diseases |
| RS1911894399 |
AIPL1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 4, Leber congenital amaurosis 4 |
| RS191190036 |
MPDZ
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS191194366 |
SLC12A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypokalemia-hypomagnesemia, Familial hypokalemia-hypomagnesemia |
| RS191195745 |
PDE6B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS191197223 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Dilated cardiomyopathy 3B |
| RS1912009292 |
GALNS
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-IV-A |
| RS1912011058 |
AIPL1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 4, Leber congenital amaurosis 4 |
| RS191201723 |
PKHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS191202700 |
FANCI
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group I |
| RS191202934 |
GH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Decreased response to growth hormone stimulation test, Decreased response to growth hormone stimulation test |
| RS191203702 |
GLB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-IV-B |
| RS191205035 |
PLD1
|
Health Risk |
Likely pathogenic |
— |
| RS1912058703 |
AIPL1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 4, Leber congenital amaurosis 4 |
| RS191205969 |
TRPM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital stationary night blindness 1C, Retinal dystrophy |
| RS191208192 |
CACNA2D2
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, Inborn genetic diseases |
| RS191211377 |
SLC34A2
|
Health Risk |
Conflicting classifications of pathogenicity |
PULMONARY ALVEOLAR MICROLITHIASIS, Lung cancer |
| RS1912124497 |
GALNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-IV-A |
| RS191213592 |
CACNA2D1
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome, Cardiovascular phenotype |
| RS191215452 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital muscular dystrophy due to partial LAMA2 deficiency, LAMA2-related muscular dystrophy |
| RS1912228419 |
AIPL1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 4, Leber congenital amaurosis 4 |
| RS191224002 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Myofibrillar myopathy 5 |
| RS191228562 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2C, Usher syndrome type 2C |
| RS1912290012 |
GALNS
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-IV-A |
| RS191230389 |
SRP54
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1912315295 |
RGS9
|
Health Risk |
Pathogenic |
— |
| RS191233787 |
COL12A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ullrich congenital muscular dystrophy 2, Bethlem myopathy 2 |
| RS1912376768 |
PIEZO1
|
Health Risk |
Likely pathogenic |
— |
| RS191237702 |
NDRG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4D |
| RS191239995 |
CPLANE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome 17, Joubert syndrome 17 |
| RS191244915 |
EPG5
|
Health Risk |
Conflicting classifications of pathogenicity |
Vici syndrome, EPG5-related disorder |
| RS191245006 |
SNRNP200
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1912453387 |
PIEZO1
|
Health Risk |
Likely pathogenic |
— |
| RS1912459271 |
PRPF8
|
Health Risk |
Pathogenic |
— |
| RS191249840 |
KNL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 4, primary |
| RS1912518161 |
PRPF8
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1912519918 |
XYLT2
|
Health Risk |
Pathogenic |
— |
| RS1912543391 |
XYLT2
|
Health Risk |
Likely pathogenic |
Spondylo-ocular syndrome, Spondylo-ocular syndrome |
| RS1912544280 |
ATP8B1
|
Health Risk |
Pathogenic/Likely pathogenic |
Progressive familial intrahepatic cholestasis, Benign recurrent intrahepatic cholestasis type 1 |
| RS1912582692 |
PRPF8
|
Health Risk |
Pathogenic |
— |
| RS1912610496 |
PRPF8
|
Health Risk |
Pathogenic |
— |
| RS1912631466 |
RGS9
|
Health Risk |
Likely pathogenic |
— |
| RS191263181 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1912636978 |
XYLT2
|
Health Risk |
Pathogenic |
— |
| RS191263754 |
CACNA1S
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant hyperthermia, susceptibility to |
| RS191266255 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1912687309 |
NXN
|
Health Risk |
Pathogenic |
Robinow syndrome, autosomal recessive 2 |
| RS1912700120 |
ACSF3
|
Health Risk |
Pathogenic/Likely pathogenic |
Combined malonic and methylmalonic acidemia, Combined malonic and methylmalonic acidemia |
| RS1912702795 |
ACSF3
|
Health Risk |
Likely pathogenic |
Combined malonic and methylmalonic acidemia, Combined malonic and methylmalonic acidemia |
| RS191270471 |
GARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS191284403 |
SLITRK1
|
Health Risk |
Pathogenic |
Tourette syndrome, Tourette syndrome |
| RS191286546 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Cardiovascular phenotype |
| RS191287362 |
ANKRD11
|
Health Risk |
Conflicting classifications of pathogenicity |
KBG syndrome, KBG syndrome |
| RS191288058 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Distal myopathy with posterior leg and anterior hand involvement |
| RS1912887899 |
ACSF3
|
Health Risk |
Pathogenic/Likely pathogenic |
Combined malonic and methylmalonic acidemia, Combined malonic and methylmalonic acidemia |
| RS1912891330 |
AIPL1
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 4, Leber congenital amaurosis 4 |
| RS1912903065 |
ATP8B1
|
Health Risk |
Pathogenic |
Familial intrahepatic cholestasis type 1, Benign recurrent intrahepatic cholestasis type 1 |
| RS1912919808 |
AIPL1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 4, Leber congenital amaurosis 4 |
| RS1912920081 |
AIPL1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 4, Leber congenital amaurosis 4 |
| RS191293319 |
ANGPTL3
|
Health Risk |
Likely pathogenic |
— |
| RS191293931 |
SLC6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Epilepsy with myoclonic atonic seizures |
| RS191295403 |
PMM2
|
Health Risk |
Pathogenic |
PMM2-congenital disorder of glycosylation, PMM2-congenital disorder of glycosylation |
| RS191297318 |
FGG
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital afibrinogenemia, Congenital afibrinogenemia |
| RS191300661 |
DSG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiomyopathy |
| RS191304573 |
FN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS191308779 |
PLEC
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1913108251 |
ATP8B1
|
Health Risk |
Likely pathogenic |
Benign recurrent intrahepatic cholestasis type 1, Benign recurrent intrahepatic cholestasis type 1 |
| RS191312027 |
ATP7B
|
Health Risk |
Pathogenic |
Wilson disease, Inborn genetic diseases |
| RS191313794 |
CYP27A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cholestanol storage disease, CYP27A1-related disorder |
| RS191317359 |
MYT1L
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Intellectual disability |
| RS191320481 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS1913249761 |
AIPL1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 4, Leber congenital amaurosis 4 |
| RS1913263 |
MGST1
|
Health Risk |
association |
Pulmonary disease, chronic obstructive |
| RS1913293128 |
ATP8B1
|
Health Risk |
Pathogenic |
— |
| RS191334763 |
KCNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Long QT syndrome 5 |
| RS191337920 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS1913405478 |
ATP8B1
|
Health Risk |
Pathogenic |
Progressive familial intrahepatic cholestasis type 1, Progressive familial intrahepatic cholestasis type 1 |
| RS191342808 |
RBM20
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1DD, Cardiomyopathy |
| RS191344898 |
TRPM6
|
Health Risk |
Conflicting classifications of pathogenicity |
Intestinal hypomagnesemia 1, Inborn genetic diseases |
| RS191346286 |
NEFL
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2E, Charcot-Marie-Tooth disease |
| RS191352124 |
GRIN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant |
| RS191354103 |
OTOG
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS191355534 |
KPNA7
|
Health Risk |
Conflicting classifications of pathogenicity |
KPNA7-related disorder, KPNA7-related disorder |